Rejuvenation
A tissue- and appearance-focused regenerative track, distinct from Longevity/Executive Health's systemic, biomarker-led focus on organ-system function and biological age.
What it is
Rejuvenation, as currently scoped, refers to a tissue- and appearance-focused regenerative track, using regenerative-injection and light-based technologies to support skin, tissue, and localized recovery, as distinct from Longevity/Executive Health's systemic, biomarker-led focus on organ-system function and biological age. This is a newly introduced program and its exact treatment set is still being finalized as our clinical protocols are confirmed.
Common symptoms & concerns
- Interest in tissue-quality, skin, or localized recovery support, distinct from systemic longevity monitoring
- Already engaged in a Longevity/Executive Health program and interested in an additional tissue-focused adjunct
- Interest in regenerative-injection or light-based technologies specifically, rather than a full diagnostic work-up
Assessment approach
Assessment for Rejuvenation is coordinated with your existing Longevity/Executive Health work-up where relevant, so it adds to rather than duplicates that diagnostic picture.
In-scope care
In-scope care is provisionally built around PRP, red light therapy, and NAD+ therapy; the confirmed treatment set and protocol sequencing will be finalized and published here once our clinical team completes scope definition.
Treatments used
Related questions
Longevity/Executive Health is a systemic, biomarker-led assessment of organ-system function and biological age, while Rejuvenation is a tissue- and appearance-focused regenerative track. The two are complementary rather than overlapping.
Provisionally, this track uses regenerative-injection and light-based technologies such as PRP, red light therapy, and NAD+ therapy, though the confirmed treatment set is pending finalisation.
Patients already engaged in a Longevity/Executive Health program may add Rejuvenation as a tissue-focused adjunct; exact protocol sequencing will be confirmed with your care team.
No claim of tissue-rejuvenation or anti-ageing outcome is made. This program's scope, evidence base, and regulatory status are still being confirmed.